{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:32:42Z","timestamp":1770838362981,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.rec.2021.02.013","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T10:27:48Z","timestamp":1621333668000},"page":"325-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness analysis of the SAPIEN 3 transcatheter aortic valve implant in patients with symptomatic severe aortic stenosis"],"prefix":"10.1016","volume":"75","author":[{"given":"Eduardo","family":"Pinar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Garc\u00eda de Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Leithold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Mart\u00ed-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Cuervo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo A.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabel","family":"Est\u00e9vez-Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2021.02.013_bib0270","first-page":"489","article-title":"Aortic stenosis: insights on pathogenesis and clinical implications","volume":"13","author":"Carit\u00e0","year":"2016","journal-title":"J Geriatr Cardiol JGC."},{"key":"10.1016\/j.rec.2021.02.013_bib0275","doi-asserted-by":"crossref","first-page":"5178631","DOI":"10.1155\/2017\/5178631","article-title":"Valve calcification in aortic stenosis: etiology and diagnostic imaging techniques","volume":"2017","author":"Izquierdo-G\u00f3mez","year":"2017","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.rec.2021.02.013_bib0280","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.119.041080","article-title":"Contemporary presentation and management of valvular heart disease: The EURObservational Research Programme Valvular Heart Disease II Survey","volume":"140","author":"Iung","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.013_bib0285","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","article-title":"A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular heart disease","volume":"24","author":"Iung","year":"2003","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.02.013_bib0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/hrt.35.1.41","article-title":"Natural history of valvular aortic stenosis","volume":"35","author":"Frank","year":"1973","journal-title":"Br Heart J."},{"key":"10.1016\/j.rec.2021.02.013_bib0295","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.95.9.2262","article-title":"Prospective study of asymptomatic valvular aortic stenosis: Clinical, echocardiographic, and exercise predictors of outcome","volume":"95","author":"Otto","year":"1997","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.013_bib0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-7120-4-27","article-title":"Epidemiology and cardiovascular risk factors of aortic stenosis","volume":"4","author":"Faggiano","year":"2006","journal-title":"Cardiovasc Ultrasound."},{"key":"10.1016\/j.rec.2021.02.013_bib0305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/RMHP.S34587","article-title":"Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients","volume":"5","author":"Clark","year":"2012","journal-title":"Risk Manag Healthc Policy."},{"key":"10.1016\/j.rec.2021.02.013_bib0310","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ejcts.2006.07.028","article-title":"Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged \u226580 years","volume":"30","author":"Varadarajan","year":"2006","journal-title":"Eur J Cardio-thoracic Surg."},{"key":"10.1016\/j.rec.2021.02.013_bib0315","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/CIRCULATIONAHA.110.983510","article-title":"Outcome of patients with low-gradient \u201csevere\u201d aortic stenosis and preserved ejection fraction","volume":"123","author":"Jander","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.013_bib0320","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/2047487312451238","article-title":"Prevalence of calcific aortic valve disease in the elderly and associated risk factors: A population-based study in a Mediterranean area","volume":"20","author":"Ferreira-Gonz\u00e1lez","year":"2013","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0325","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/eurheartj\/ehy107","article-title":"Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections","volume":"39","author":"Durko","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.02.013_bib0330","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.recesp.2016.01.013","article-title":"Cost-effectiveness analysis: why and how","volume":"69","author":"Campillo-Artero","year":"2016","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0335","unstructured":"EQ-5D Value Sets: inventory, comparative review and user guide. Amsterdam: Springer Netherlands; 2007."},{"key":"10.1016\/j.rec.2021.02.013_bib0340","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jval.2012.06.016","article-title":"Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2","volume":"15","author":"Roberts","year":"2012","journal-title":"Value Heal J Int Soc Pharmacoeconomics Outcomes Res."},{"key":"10.1016\/j.rec.2021.02.013_bib0345","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2021.02.013_bib0350","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jacc.2019.09.007","article-title":"Health status after transcatheter versus surgical aortic valve replacement in low-risk patients with aortic stenosis","volume":"74","author":"Baron","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0355","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement","volume":"382","author":"Makkar","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2021.02.013_bib0360","article-title":"An\u00e1lisis coste-efectividad del recambio valvular a\u00f3rtico mediante pr\u00f3tesis valvular percut\u00e1nea frente al tratamiento quir\u00fargico habitual. Ministerio de Sanidad, Servicios Sociales e Igualdad; Servicio de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias del Pa\u00eds Vasco","author":"Bay\u00f3n","year":"2014","journal-title":"Informes de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias: OSTEBA"},{"key":"10.1016\/j.rec.2021.02.013_bib0365","article-title":"Desarrollo de indicaciones de uso apropiado del implante transcat\u00e9ter de pr\u00f3tesis valvular a\u00f3rtica (TAVI) en el tratamiento de la estenosis a\u00f3rtica grave sintom\u00e1tica","author":"Queiro","year":"2014","journal-title":"Red Espa\u00f1ola de Agencias de Evaluaci\u00f3n de Tecnolog\u00edas y Prestaciones del SNS, Axencia de Avaliaci\u00f3n de Tecnolox\u00edas Sanitarias de Galicia"},{"key":"10.1016\/j.rec.2021.02.013_bib0370","article-title":"Ventajas diferenciales de las distintas pr\u00f3tesis percut\u00e1neas de reemplazo de v\u00e1lculas a\u00f3rticas. Estudio de personalizaci\u00f3n. Red Espa\u00f1ola de Agencias de Evaluaci\u00f3n de Tecnolog\u00edas y Prestaciones del SNS, Unidad Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias de Madrid","author":"Jurado","year":"2017","journal-title":"Informes de evaluaci\u00f3n de tecnolog\u00edas sanitarias"},{"key":"10.1016\/j.rec.2021.02.013_bib0375","first-page":"477","article-title":"A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients","volume":"11","author":"Tarride","year":"2019","journal-title":"Clin outcomes Res CEOR."},{"key":"10.1016\/j.rec.2021.02.013_bib0380","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/13696998.2018.1559600","article-title":"Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients","volume":"22","author":"Goodall","year":"2019","journal-title":"J Med Econ."},{"key":"10.1016\/j.rec.2021.02.013_bib0385","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2021.02.013_bib0390","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2021.02.013_bib0395","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0140-6736(16)30073-3","article-title":"Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis","volume":"387","author":"Thourani","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2021.02.013_bib0400","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.116.022797","article-title":"One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis","volume":"134","author":"Herrmann","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.013_bib0405","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2014.12.109","article-title":"Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants","volume":"182","author":"Ribera","year":"2015","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0410","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: The valve academic research consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0415","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/0272989X12472398","article-title":"Survival analysis for economic evaluations alongside clinical trials\u2014extrapolation with patient-level data: inconsistencies, limitations, and a practical guide","volume":"33","author":"Latimer","year":"2013","journal-title":"Med Decis Mak."},{"key":"10.1016\/j.rec.2021.02.013_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40277-013-0001-z","article-title":"Evidencia del coste-efectividad de la implantaci\u00f3n transcat\u00e9ter de la pr\u00f3tesis valvular a\u00f3rtica (TAVI) Edwards SAPIEN en pacientes de alto riesgo con estenosis a\u00f3rtica sintom\u00e1tica en Espa\u00f1a: resultados preliminares","volume":"10","author":"Ferreira-Gonz\u00e1lez","year":"2013","journal-title":"PharmacoEconomics Spanish Res Artic."},{"key":"10.1016\/j.rec.2021.02.013_bib0425","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.recesp.2014.08.010","article-title":"Cost-effectiveness analysis comparing apixaban and acenocoumarol in the prevention of stroke in patients with nonvalvular atrial fibrillation in Spain","volume":"68","author":"Bar\u00f3n Esquivias","year":"2015","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0430","unstructured":"Subdirecci\u00f3n General de Informaci\u00f3n Sanitaria e Innovaci\u00f3n. Ministerio de Sanidad SS e I. Norma Estatal RAE-CMBD 2016 \u2013 Nota Informativa. Disponible en: https:\/\/www.mscbs.gob.es\/estadEstudios\/estadisticas\/docs\/CMBD\/Nota_difus_Norma_Estatal_2017.pdf. Consultado 18 Mar 2018."},{"key":"10.1016\/j.rec.2021.02.013_bib0435","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10198-016-0799-9","article-title":"Economic impact of patients admitted to stroke units in Spain","volume":"18","author":"Alvarez-Sab\u00edn","year":"2017","journal-title":"Eur J Heal Econ HEPAC Heal Econ Prev care."},{"key":"10.1016\/j.rec.2021.02.013_bib0440","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.recesp.2013.12.016","article-title":"Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain","volume":"67","author":"Delgado","year":"2014","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1524-4733.2009.00655.x","article-title":"Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model","volume":"13","author":"Mar","year":"2010","journal-title":"Value Heal J Int Soc Pharmacoeconomics Outcomes Res."},{"key":"10.1016\/j.rec.2021.02.013_bib0450","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamacardio.2017.2039","article-title":"Health status benefits of transcatheter vs surgical aortic valve replacement in patients with severe aortic stenosis at intermediate surgical risk: results from the PARTNER 2 randomized clinical trial","volume":"2","author":"Baron","year":"2017","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0455","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jcin.2018.02.032","article-title":"Effect of SAPIEN 3 transcatheter valve implantation on health status in patients with severe aortic stenosis at intermediate surgical risk: results from the PARTNER S3i trial","volume":"11","author":"Baron","year":"2018","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2021.02.013_bib0460","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10198-010-0244-4","article-title":"Spanish recommendations on economic evaluation of health technologies","volume":"11","author":"L\u00f3pez-Bastida","year":"2010","journal-title":"Eur J Heal Econ."},{"key":"10.1016\/j.rec.2021.02.013_bib0465","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2013.08.1666","article-title":"Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial","volume":"64","author":"Svensson","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0470","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.recesp.2016.06.026","article-title":"Will TAVI be the standard of care in the treatment of aortic stenosis?","volume":"69","author":"Mor\u00eds","year":"2016","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2021.02.013_bib0475","author":"Vallejo-Torres","year":"2015","journal-title":"Valor monetario de un a\u00f1o de vida ajustado por calidad: estimaci\u00f3n emp\u00edrica del coste de oportunidad en el Sistema Nacional de Salud."},{"key":"10.1016\/j.rec.2021.02.013_bib0480","unstructured":"Vallejo-Torres L, Garc\u00eda-Lorenzo B, Rivero-Arias O, Pinto-Prades J, Serrano-Aguilar P. Disposici\u00f3n a pagar de la sociedad espa\u00f1ola por un a\u00f1o de vida ajustado por calidad. Ministerio de Sanidad, Servicios Sociales e Igualdad, Servicio de Evaluaci\u00f3n del Servicio Canario de Salud. Disponible en: https:\/\/www3.gobiernodecanarias.org\/sanidad\/scs\/contenidoGenerico.jsp?idDocument=5512e173-4210-11e7-952b-a987475f03d3&idCarpeta=ae273cd1-b385-11e9-82f7-8d5cff9227e6. Consultado 18 Mar 2020."},{"key":"10.1016\/j.rec.2021.02.013_bib0485","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.gaceta.2019.06.010","article-title":"Once a\u00f1os de evaluaciones econ\u00f3micas de productos sanitarios en la Red de Agencias de Evaluaci\u00f3n. Calidad metodol\u00f3gica e impacto del coste-utilidad","volume":"34","author":"Gim\u00e9nez","year":"2020","journal-title":"Gac Sanit."},{"key":"10.1016\/j.rec.2021.02.013_bib0490","article-title":"Regorafenib en tumores del estroma gastrointestinal Abril 2015. Informe Compartido del Grupo GENESIS-SEFH (Revisor)","author":"Gonz\u00e1lez","year":"2015","journal-title":"Madrid: SEFH"},{"key":"10.1016\/j.rec.2021.02.013_bib0495","author":"Mateo","year":"2016","journal-title":"Nivolumab en carcinoma de c\u00e9lulas renales. informe compartido del grupo genesis-sefh"},{"key":"10.1016\/j.rec.2021.02.013_bib0500","article-title":"Palbociclib en c\u00e1ncer de mama metast\u00e1sico","author":"Mateo","year":"2020","journal-title":"Informe compartido del grupo GENESIS-SEFH 2017."},{"key":"10.1016\/j.rec.2021.02.013_bib0505","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCULATIONAHA.118.035236","article-title":"Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk","volume":"139","author":"Baron","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.013_bib0510","first-page":"E149","article-title":"Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis","volume":"92","author":"Tummala","year":"2018","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv."},{"key":"10.1016\/j.rec.2021.02.013_bib0515","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCULATIONAHA.119.043785","article-title":"Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a propensity-matched comparison from the FRANCE-TAVI Registry","volume":"141","author":"Van Belle","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.013_bib0520","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.119.043971","article-title":"Impact of SAPIEN 3 balloon-expandable versus Evolut R self-expandable transcatheter aortic valve implantation in patients with aortic stenosis: data from a nationwide analysis","volume":"141","author":"Deharo","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.013_bib0525","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1161\/CIRCULATIONAHA.118.036866","article-title":"Five-year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients","volume":"138","author":"Didier","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.013_bib0530","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/eurheartj\/ehv756","article-title":"TAVI or no TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation","volume":"37","author":"Puri","year":"2016","journal-title":"Eur Heart J."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585721001304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585721001304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:00:21Z","timestamp":1761822021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585721001304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1885585721001304"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2021.02.013","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of the SAPIEN 3 transcatheter aortic valve implant in patients with symptomatic severe aortic stenosis","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2021.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2021.02.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}